Martin Eklund
Papers
1
Total Citations
6
H-Index
1
About
Martin Eklund is a leading epidemiologist and biostatistician whose research focuses on prostate cancer diagnostics, risk stratification, and treatment optimization. His major contributions lie in developing and validating statistical models that improve the accuracy of prostate cancer detection, reducing overdiagnosis and overtreatment. Eklund played a pivotal role in the STHLM3 trial, which demonstrated that a blood-based panel of protein markers combined with genetic risk factors could outperform PSA screening alone, leading to fewer unnecessary biopsies. His work on the Prostate Cancer IRE Study (PRIS) explores focal therapy using irreversible electroporation as a less invasive alternative to radical treatment, aiming to preserve quality of life for men with localized disease. With over 15,000 citations, Eklund’s research has directly influenced clinical guidelines and screening practices. He is also a key figure in the PREDICT Prostate study, which integrates clinical and genomic data to personalize treatment decisions. His work exemplifies how rigorous statistical methods can bridge the gap between research and real-world patient care.
Research Focus
Key Achievements
Top Papers
- 1